sodium iodide i-131
Trade name: iodotope
Small moleculeapproved
Approved
May 2, 1957
Clinical trial activity
2 trials · 4 clinical orgs · 6 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 15, 2021 (NCT04952493)
Timeline
1950s
1970s
- Aug 18, 1971
Curium Pharma — NDA Secondary Org
- Nov 9, 1976
Jubilant DraxImage Inc. — Marketing Organization
- Nov 16, 1976
Sun Pharmaceuticals — Marketing Organization
2000s
- Jan 24, 2003
Jubilant DraxImage Inc. — NDA Secondary Org
2020s
- Feb 5, 2020
International Isotopes — Marketing Organization
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
- Jun 12, 2025
Cardinal Health — Marketing Organization
Indications
Approved for
Mechanism of action
- DNADISRUPTING AGENT
DNA disrupting agent
Approval history
- approvedMay 2, 1957
Chemistry & pharmacology
Loading structure…
SMILES
[131I-].[Na+]- Mol. weight
- 153.9 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
- Delivery
- Oral
- Availability
- Prescription Only
Oral
Yes
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1201084 ↗
Also known as
- hicon
- hicon
- iodotope
- iodotope
- iodotope
- iodotope
- iodotope i-131
- iodotope i-131
- iodotope therapeutic
- iodotope therapeutic
- oriodide
- oriodide
- radiocaps-131
- radiocaps-131
- sodium iodide (131i)
- sodium iodide (131i)
- sodium iodide (131i)
- sodium iodide (131i)
- sodium iodide (131i)
- sodium iodide (131i) capsules
- sodium iodide (131i) capsules
- sodium iodide i 131
- sodium iodide i 131
- sodium iodide i 131
- sodium iodide i-131
- sodium iodide i-131
- sodium iodide i-131
- sodium iodide i-131
- sodium iodide i-131
- theriodide
- theriodide
- tracervial-131
- tracervial-131
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05668962 | Phase 2 | Jan 31, 2023 | Eli Lilly, Harvard University |
| NCT04952493 | Phase 2 | Aug 15, 2021 | Chinese Academy of Medical Sciences, Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Eli Lilly | For profit | 1 | 0 | 1 | 2023 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd | For profit | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1
Marketing (9)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Bracco | For profit | NDA2 | May 2, 1957 |
| Bracco | For profit | NDA | May 2, 1957 |
| Cardinal Health | Academic/Hospital | MKTG | Jun 12, 2025 |
| Curium Pharma | For profit | NDA2 | Aug 18, 1971 |
| International Isotopes | For profit | MKTG | Feb 5, 2020 |
| Jubilant DraxImage Inc. | For profit | NDA2 | Jan 24, 2003 |
| Jubilant DraxImage Inc. | For profit | MKTG | Nov 9, 1976 |
| Jubilant DraxImage Inc. | For profit | SYN | Jan 24, 2003 |
| Sun Pharmaceuticals | For profit | MKTG | Nov 16, 1976 |